Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Observation on the first line of the Nikkei 225: Highly similar to 1999, investors are being forced to participate in what may be a "once-in-a-lifetime" bull market.
Bank of America's "macro picture" for the next decade: the first 5 years will see "continued inflation," followed by "super deflation" in the next 5 years?
Huachuang Securities April Overseas Monthly Observation: Energy Inflation Further Fermentation, Four Major Central Banks Cautiously Weighing Options
Observation on the first line of the Nikkei 225: Highly similar to 1999, investors are being forced to participate in what may be a "once-in-a-lifetime" bull market.
Bank of America's "macro picture" for the next decade: the first 5 years will see "continued inflation," followed by "super deflation" in the next 5 years?
Huachuang Securities April Overseas Monthly Observation: Energy Inflation Further Fermentation, Four Major Central Banks Cautiously Weighing Options
